Cargando…
Proposed brachytherapy recommendations (practical implementation, indications, and dose fractionation) during COVID-19 pandemic
Autores principales: | Mohindra, Pranshu, Beriwal, Sushil, Kamrava, Mitchell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Brachytherapy Society. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252026/ https://www.ncbi.nlm.nih.gov/pubmed/32423787 http://dx.doi.org/10.1016/j.brachy.2020.04.009 |
Ejemplares similares
-
Single-fraction high-dose-rate brachytherapy: a scoping review on outcomes and toxicities for all disease sites
por: Kazemi, Mehdi, et al.
Publicado: (2022) -
High-dose-rate fractionated brachytherapy monotherapy for localized prostate cancer: a systematic review and meta-analysis
por: Anderson, Eric M., et al.
Publicado: (2021) -
Advances in management of locally advanced cervical cancer
por: Musunuru, Hima Bindu, et al.
Publicado: (2021) -
Brachytherapy for malignancies of the vagina in the 3D era
por: Glaser, Scott M., et al.
Publicado: (2015) -
High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina
por: Beriwal, Sushil, et al.
Publicado: (2008)